Tharimmune enters $0.0001 par value common stock ATM facility with Rodman & Renshaw

Canton Strategic Holdings, Inc.

ATM Agreement allows Tharimmune to sell shares of common stock from time to time through Rodman & Renshaw as sales agent.
Sales will be made by methods deemed "at the market" under Rule 415(a)(4), including direct sales on Nasdaq.
Manager receives 3.0% commission on gross proceeds; no obligation for Tharimmune to sell any shares.
Shares offered under effective shelf registration statement (333-270684) and prospectus supplement dated June 7, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.